IBEX Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IBEX research report →
Range $20 – $29
Price Chart
About the company
IBEX Limited is a global enterprise that specializes in delivering comprehensive, technology-powered solutions designed to manage the entire customer lifecycle for businesses. Their service portfolio is built around three core solutions: ibex Connect: This customer engagement platform covers vital services such as customer care, technical assistance, revenue generation initiatives, and other outsourced back-office functions. It employs an integrated CX model, leveraging various communication channels including voice, email, chat, SMS, and social media.
- CEO
- Robert T. Dechant
- IPO
- 2020
- Employees
- 35,000
- HQ
- Washington, DC, US
Get TickerSpark's AI analysis on IBEX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $582.63M
- P/E
- 12.61
- Fwd P/E
- 11.76
- PEG
- 0.37
- P/S
- 0.90
- P/B
- 3.42
- EV/EBITDA
- 7.94
- Div Yield
- 0.00%
- Gross Margin
- 29.17%
- Op Margin
- 8.53%
- Net Margin
- 7.19%
- ROE
- 29.46%
- ROIC
- 20.49%
Latest fiscal year · YoY change
- Revenue
- $644.08M+15.4%
- Gross Profit
- $187.91M+8.9%
- Op Income
- $54.96M
- Net Income
- $46.33M+25.7%
- EPS
- $3.45+37.5%
- OCF Growth
- +29.2%
- FCF Growth
- +14.3%
- 52W High
- $45.28
- 52W Low
- $23.40
- 50D MA
- $38.57
- 200D MA
- $33.53
- Beta
- 0.72
- RSI (14)
- 64
- Avg Volume
- 120.90K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
IBEX delivered another record quarter and year, with double-digit revenue growth, expanding AI-led differentiation, and fiscal 2027 guidance pointing to continued growth.· September 10, 2026
- Q4 revenue rose 12% to $164.3 million, marking the sixth straight quarter of double-digit growth.
- Full-year revenue increased 15.4% to $644.1 million, with record adjusted EBITDA, EPS, operating cash flow, and free cash flow.
- HealthTech was a standout, growing 42% in Q4 to $29.4 million and 38% for the full year to $114 million, well above the company’s $100 million target.
- IBEX said AI agent deployments are gaining traction across five verticals, with case studies showing resolution rates above 20% to 40% and CSAT above 4.7 out of 5.0.
- Management guided fiscal 2027 revenue to $700 million to $715 million and adjusted EBITDA to $90 million to $94 million.
Fourth-quarter revenue was $164.3 million, up 12% from $147.1 million a year ago. GAAP net income was $8.7 million versus $9.6 million last year, GAAP EPS was $0.59 versus $0.66, adjusted EBITDA was $20.2 million versus $20.5 million, adjusted EBITDA margin was 12.3% versus 13.9%, adjusted net income was $12.7 million, and adjusted EPS was $0.85 versus $0.87. Full-year revenue was $644.1 million, up 15.4% from $558.3 million; GAAP net income was $46.3 million versus $36.9 million; GAAP EPS rose 32.8% to $3.13; adjusted EBITDA increased to $82.4 million from $72 million; adjusted EBITDA margin was 12.8% versus 12.9%; adjusted net income rose 21% to $52.2 million; adjusted EPS rose 28% to $3.52; operating cash flow was a record $59 million; and free cash flow was a record $31.2 million. Q4 gross margin was 28.6%. For fiscal 2027, IBEX guided revenue to $700 million to $715 million, representing 9% to 11% growth, adjusted EBITDA to $90 million to $94 million, or 9% to 14% growth, first-quarter revenue to $168 million to $170 million, and first-quarter adjusted EBITDA to $22 million to $23 million. Capital expenditures are expected to be $25 million to $30 million, and management expects the tax rate to be 20% to 22%.
CEO Bob Dechant framed fiscal 2026 as a banner year and said IBEX is widening its separation from traditional BPO competitors. He emphasized a “flywheel” of differentiation, new-logo wins, strong retention, and high client satisfaction, while highlighting that AI agents with Sierra are turning a perceived threat into a growth opportunity. His tone was confident and expansive, especially around the company’s ability to lead with AI and then expand into traditional human-agent work.
CFO Taylor Greenwald focused on the operating leverage beneath the top line: Q4 revenue grew 12% to $164.3 million, but margins were pressured by new-client training costs, work shifting from nearshore to offshore, and higher fuel/utility costs. She noted Q4 adjusted EBITDA was $20.2 million, adjusted EBITDA margin was 12.3%, and full-year adjusted EBITDA reached a record $82.4 million with free cash flow of $31.2 million and operating cash flow of $59 million. She also pointed to a strong balance sheet, with $32.6 million of cash, $1.7 million of debt, net cash of $30.9 million, a renewed HSBC revolver through October 2029 with up to $76 million of capacity, and $17.9 million remaining under the share repurchase authorization.
Analysts focused on whether AI was already helping growth and whether it could become a bigger driver. Management said the Sierra partnership improves differentiation and is accelerating both traditional business and AI-agent opportunities, with proof-of-concept deployments moving quickly to full rollout and meaningful enterprise volume. They also asked about the lower Q4 tax rate; CFO said it was helped by discrete items and that the normalized rate should be 20% to 22% going forward. On verticals, management said HealthTech, ecommerce, and travel are all seeing strong pipelines and that the 9 new Q4 logos were not a one-off.
The bull case from this call is that IBEX is still growing rapidly while also improving its strategic positioning. Management said AI agents are not cannibalizing revenue and instead are helping win new logos, expand existing accounts, and take share from competitors across multiple verticals. The balance sheet, cash flow generation, and renewed credit facility also give the company room to keep investing while returning capital through buybacks.
The main risks discussed were margin pressure from client ramp costs, work-location transitions, and higher fuel-related expenses, which pushed Q4 adjusted EBITDA margin down to 12.3% from 13.9%. Management also acknowledged that some growth depends on continued execution in new AI deployments and ongoing client wins, so the current momentum has to persist to justify the FY27 guide. Investors may also note the normalization of the tax rate back to 20% to 22%, which is less favorable than the Q4 level.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 81.3%
- Shares Outstanding
- 13.39M
- Float Shares
- 10.89M
of shares held by institutions
167 13F filers
Buy/sell ratio 0.58. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 1.04M | ▲ 75.73K |
| American Century Companies Inc | 510.63K | ▼ 170.14K |
| Dimensional Fund Advisors LP | 385.15K | ▲ 26.96K |
| Two Sigma Investments, LP | 380.61K | ▼ 2.89K |
| Ameriprise Financial Inc | 374.74K | ▲ 37.24K |
| Royce & Associates LP | 372.58K | ▲ 7.92K |
| Vanguard Capital Management LLC | 352.45K | ▲ 352.45K |
| Boston Partners | 344.71K | ▲ 57.65K |
| Acadian Asset Management LLC | 299.60K | ▼ 113.96K |
| Jpmorgan Chase & Co | 299.22K | ▼ 41.19K |
| Hillsdale Investment Management Inc. | 291.10K | ▲ 26.90K |
| Wellington Management Group Llp | 276.78K | ▼ 3.60K |
Held by 137 ETFs
Biggest fund positions in IBEX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 30, 26 | Ringman Michael | other | 9,038 |
| Sep 30, 26 | Ringman Michael | other | 2,599 |
| Sep 30, 26 | Darwal Michael Joseph | other | 2,348 |
| Sep 30, 26 | Darwal Michael Joseph | other | 843 |
| Sep 30, 26 | Afdahl David Martin | other | 3,228 |
| Sep 30, 26 | Afdahl David Martin | other | 1,590 |
| Sep 30, 26 | Casteel Julie K | other | 3,228 |
| Sep 30, 26 | Casteel Julie K | other | 1,271 |
| Sep 30, 26 | Dawson Bruce Neil | other | 3,228 |
| Sep 30, 26 | Dawson Bruce Neil | other | 1,413 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our IBEX coverage
Recent articles, reports, and earnings notes.
No research on IBEX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IBEX report →IBEX (NASDAQ:IBEX) Sets New 1-Year High – Should You Buy?
defenseworld.net · Sep 25
ibex Wins 2026 Product of the Year Award from CUSTOMER Magazine
globenewswire.com · Sep 24
ibex Wins 2026 Globee® Award for AI-Powered Customer Experience Solution Excellence
globenewswire.com · Sep 16
IBEX Limited (IBEX) Q4 2026 Earnings Call Transcript
seekingalpha.com · Sep 10
IBEX Q4 Earnings Call Highlights
marketbeat.com · Sep 10
IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance
globenewswire.com · Sep 10
ibex Expands Global Service Delivery Network with New State-of-the-Art Center in Egypt
globenewswire.com · Sep 2
IBEX Limited to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 10, 2026
globenewswire.com · Aug 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.